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Case: An eighty year old African-American female was evaluated for cough, chest pain, asymptomatic
anemia and 21 pound weight loss over a six month period. Computerized tomography (CT) revealed a
spiculated 2.8 cm right upper lobe lung nodule, other smaller nodules and lymphadenopathy. Gallium
scan revealed abnormal uptake of radiotracer in lacrimal, hilar and mediastinal glands. Broncho-alveolar
lavage showed CD4/CD8 ratio of 2:1 with 15% lymphocytes. Biopsy of right upper lobe lesion and
mediastinoscopic lymph node biopsy showed numerous matured uniform non-caseating granulomatous
inﬂammation, however stains and culture for Acid fast bacilli (AFB)/fungal organisms were negative.
Patient improved on oral steroids. Six months later she returned with worsening dyspnea and chest X-ray
showed bilateral pleural effusions. Thoracocentesis revealed Thyroid transcription factor 1 (TTF1) positive
adenocarcinoma cells and Video assisted thoracic surgery (VATS) procedure revealed numerous pleural,
pericardial, diaphragmatic metastasis. Biopsy also was positive for TTF1 adenocarcinoma and positive for
Epidermal Growth Factor receptor (EGFR) mutation, however negative for Anaplastic Lymphoma Kinase
(ALK). Talc pleurodesis was performed. She was treated with erlotinib while steroid was kept on hold.
Initial tumor burden decreased but follow-up PET scan six months later showed progression of tumor
with lymphadenopathy. After discussion with patient and family, patient opted for hospice care.
Discussion: Oncocentric theory postulates sarcoidosis as an immunological reaction to dispersal of tumor
antigen. Sarcocentric theory postulates that cell-mediated immune abnormalities induced by sarcoidosis
in CD4 and CD8 cells is involved in the onset of lung cancer. Thus considerable controversy exists
regarding sarcoidosis and malignancy. In our case, TTF1 adenocarcinoma cells from thoracocentesis
suggest peripheral nodules in right upper lobe and lingula were likely metastatic, presenting as malig-
nant pleural effusions. However if noncaseating granulomatous inﬂammation is expected as an immu-
nological reaction to tumor antigen, it is very interesting to observe that initial tissue biopsy of primary
right upper lobe mass and mediastinal lymph nodes showed matured uniform non-caseating granulo-
matous inﬂammation and no evidence of adenocarcinoma. This being said, it would be highly unlikely
for sarcoidosis to progress to lung adenocarcinoma within six months. This adds further controversy to
whether granulomatous inﬂammation is a precursor to future malignancy or whether this elderly
African-American female was predisposed to develop granulomatous inﬂammation in presence of a
tumor antigen. One can also speculate whether repeat tissue sampling from right upper lobe mass would
have shown granulomatous inﬂammation or TTF1 adenocarcinoma.
Conclusion: While evidence is still lacking regarding association between sarcoidosis and lung adeno-
carcinoma, it is important for clinicians to exclude metastatic malignancy in patients exhibiting clinical
and radiographic ﬁndings consistent with sarcoidosis.
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An eighty year old African-American female was evaluated for
cough, chest pain, asymptomatic anemia and 21 pound weight loss
over a six month period. Computerized tomography of chest,sh Meadows, NY 11366, USA.
alia).
Ltd. Open access under CC BY-NC-SAabdomen and pelvis revealed a spiculated right upper lobe lung
nodule measuring 2.8 cm (Fig. 1); 3 mm nodule in right upper lobe,
2 mm nodule in lingula, with mediastinal and hilar lymphadenop-
athy (Fig. 2); however no pelvic or abdominal lymphadenopathy
was noted. Gallium scan showed abnormal uptake of radiotracer in
lacrimal, hilar and mediastinal glands. Broncho-alveolar lavage
(BAL) showed a CD4/CD8 ratio of 2:1 with 15% lymphocytes. Trans-
bronchial biopsy of right upper lobe lesion and mediastinoscopic
lymph node biopsy of levels II, III, IV, VII was done which revealed license.
Fig. 1. Right upper lobe lung nodule.
Fig. 3. Mediastinoscopic lymph node biopsy releaving non-caseating granulomatous
inﬂammation.
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(Fig. 3). Stains and culture for AFB and fungal organisms on biopsy
were negative. Because ofweight loss and cough patientwas started
on oral steroids and symptoms markedly improved. However she
returned sixmonths laterwithworsening shortness of breath. Chest
X-rayat the time showedbilateral pleural effusions. Thoracocentesis
was performedwhich showed Thyroid transcription factor-1 (TTF1)
positive adenocarcinoma cells. Video assisted thoracic surgery was
performed for staging and revealed numerous pleural, pericardial
and diaphragmatic metastasis. Biopsy also was positive for TTF1
positive adenocarcinoma cells (Fig. 4). Epidermal Growth factor
mutation (EGFR) mutation was positive and Anaplastic Lymphoma
kinase (ALK) mutation was negative. There was no evidence of
thyroid cancer. Talc pleurodesis was performed for symptomatic
relief of pleural effusions. Shewas treatedwith erlotinib and steroid
was kept on hold. Initial tumor burden decreased but follow-up PET
scan after six months of therapy showed progression of right upper
lobe mass and new upper abdominal and right supraclavicular
lymphadenopathy. After discussionwith patient and family, patient
declined to undergo repeat tissue sampling and decided to stop
chemotherapy, therefore hospice care was initiated.
Discussion
Epidemiological studies and linkage analysis have provided
evidence that sarcoidosis and malignancy may be etiologicallyFig. 2. Mediastinal lymphadenopathy with right upper lobe lesion.related in at least 25% of cases in which both are present [1]. The
link between sarcoidosis and lung cancer has been controversial
ever since 1973 when Brincker and Wilbek proposed that the dis-
ease sarcoidosis can induce the development of solid neoplasms by
an unknown mechanism [2]. It has been postulated that lung
cancer originates in ﬁbrous tissue found with sarcoidosis [3].
Another theory postulates that cell-mediated immune abnormal-
ities induced by sarcoidosis is involved in the onset of lung cancer
[3]. Therealso exists an oncocentric theory that postulates
sarcoidosis as an immunological reaction to dispersal of tumor
antigens [4]. This concept originates from observations of variety of
solid and lympho-hematogenous malignancies eliciting systemic
granulomatous response that is indistinguishable from sarcoidosis
[4,5]. Thus considerable controversy exists regarding association
between sarcoidosis and malignancy raising the question of cau-
sality. In our case, initial tissue biopsy of primary right upper lobe
mass along with mediastinal lymph nodes showed matured uni-
form non-caseating granulomatous inﬂammationwith no evidence
of adenocarcinoma. However repeat thoracocentesis done six
months later showed TTF1 positive adenocarcinoma cells sug-
gesting peripheral nodules in right upper lobe and lingula were
likely metastatic. If non-caseating granulomatous inﬂammation isFig. 4. Pleural biopsy with Video assisted thoracic surgery revealing non-small cell
adenocarcinoma of lung.
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interesting to observe that initial biopsy was negative for malig-
nancy. This being said, it would be highly unlikely for sarcoidosis to
progress to lung adenocarcinoma within six months. This adds
further controversy to whether granulomatous inﬂammation is a
precursor to future malignancy or whether this elderly African-
American female was predisposed to develop granulomatous
inﬂammation in presence of a tumor antigen, making it impossible
to determine a cause vs effect relation. Further clinical studies are
warranted to determine if any association does exist, however
currently the two are managed as if they exist separately.
Conclusion
While evidence is still lacking regarding association between
sarcoidosis and lung adenocarcinoma, it is important for cliniciansto exclude metastatic malignancy in patients exhibiting clinical and
radiographic ﬁndings consistent with sarcoidosis.Funding
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